These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22823097)

  • 21. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
    Falamarzian A; Lavasanifar A
    Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled release formulations of risperidone antipsychotic drug in novel aliphatic polyester carriers: Data analysis and modelling.
    Siafaka PI; Barmpalexis P; Lazaridou M; Papageorgiou GZ; Koutris E; Karavas E; Kostoglou M; Bikiaris DN
    Eur J Pharm Biopharm; 2015 Aug; 94():473-84. PubMed ID: 26159838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of a star amphiphilic block copolymer from poly(epsilon-caprolactone) and poly(ethylene glycol) as a potential drug delivery carrier.
    Wang F; Bronich TK; Kabanov AV; Rauh RD; Roovers J
    Bioconjug Chem; 2005; 16(2):397-405. PubMed ID: 15769095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-assembled micelles of biodegradable triblock copolymers based on poly(ethyl ethylene phosphate) and poly(-caprolactone) as drug carriers.
    Wang YC; Tang LY; Sun TM; Li CH; Xiong MH; Wang J
    Biomacromolecules; 2008 Jan; 9(1):388-95. PubMed ID: 18081252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
    Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Smart' delivery systems for biomolecular therapeutics.
    Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
    Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
    Fang F; Gong CY; Dong PW; Fu SZ; Gu YC; Guo G; Zhao X; Wei YQ; Qian ZY
    Biomed Mater; 2009 Apr; 4(2):025002. PubMed ID: 19208940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling of drug release from biodegradable polymer blends.
    Lao LL; Venkatraman SS; Peppas NA
    Eur J Pharm Biopharm; 2008 Nov; 70(3):796-803. PubMed ID: 18577449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: sol-gel-sol transition and drug delivery behavior.
    Gong C; Shi S; Wu L; Gou M; Yin Q; Guo Q; Dong P; Zhang F; Luo F; Zhao X; Wei Y; Qian Z
    Acta Biomater; 2009 Nov; 5(9):3358-70. PubMed ID: 19470411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate-functionalized polymeric micelles for tumor targeted delivery of a potent multidrug-resistance modulator FG020326.
    Yang X; Deng W; Fu L; Blanco E; Gao J; Quan D; Shuai X
    J Biomed Mater Res A; 2008 Jul; 86(1):48-60. PubMed ID: 17941015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel.
    Lundberg BB
    Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of hydrophilic chain length and iRGD on drug delivery from poly(ε-caprolactone)-poly(N-vinylpyrrolidone) nanoparticles.
    Zhu Z; Xie C; Liu Q; Zhen X; Zheng X; Wu W; Li R; Ding Y; Jiang X; Liu B
    Biomaterials; 2011 Dec; 32(35):9525-35. PubMed ID: 21903260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrotropic polymer micelles as versatile vehicles for delivery of poorly water-soluble drugs.
    Kim JY; Kim S; Pinal R; Park K
    J Control Release; 2011 May; 152(1):13-20. PubMed ID: 21352878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
    Wei X; Gong C; Shi S; Fu S; Men K; Zeng S; Zheng X; Gou M; Chen L; Qiu L; Qian Z
    Int J Pharm; 2009 Mar; 369(1-2):170-5. PubMed ID: 19028556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters.
    Beck-Broichsitter M; Schmehl T; Gessler T; Seeger W; Kissel T
    J Control Release; 2012 Feb; 157(3):469-77. PubMed ID: 21930166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards the development of polycaprolactone based amphiphilic block copolymers: molecular design, self-assembly and biomedical applications.
    Li Z; Tan BH
    Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():620-34. PubMed ID: 25491872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a poly-epsilon-caprolactone polymeric drug delivery device built by selective laser sintering.
    Leong KF; Wiria FE; Chua CK; Li SH
    Biomed Mater Eng; 2007; 17(3):147-57. PubMed ID: 17502691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymers for biodegradable medical devices. X. Microencapsulation studies: control of poly-hydroxybutyrate-hydroxyvalerate microcapsules porosity via polycaprolactone blending.
    Embleton JK; Tighe BJ
    J Microencapsul; 1993; 10(3):341-52. PubMed ID: 8377092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.